Key facts
- This page summarizes Sanjay Shrivastava's Form 4 filing for enVVeno Medical Corp (NVNO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 26 Dec 2024, 16:30.
Sanjay Shrivastava - 24 Dec 2024 Form 4 Insider Report for enVVeno Medical Corp (NVNO)
- Reporting relationship
- Director
- Issuer ticker
- NVNO
- Reported as of
- 24 Dec 2024
- Net transaction value
- +$15,660
- SEC form
- 4
- Accepted by SEC
- 26 Dec 2024, 16:30:21 UTC
- Prior SEC filing
- 20 Dec 2024
- Next SEC filing
- 15 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sanjay Shrivastava
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sanjay Shrivastava filed Form 4 for enVVeno Medical Corp (NVNO) on 26 Dec 2024.
Change
- Previous filing in this sequence was filed on 20 Dec 2024.
- Current net transaction value: +$15,660.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NVNO
transaction
Common Stock
Purchase
- Transaction value
- $15,660
- Shares
- +5,400
- Change %
- +139%
- Price
- $2.90
- Shares after
- 9,288
- Date
- 24 Dec 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
On December 24, 2024 the reporting person purchased 5,400 shares of common stock in the public market at $2.90 per share.